Effect of Exenatide on Cortisol Secretion

• Status: Completed
• Trial end date: 2017-12-28
• Target enrollment: 0
• Participant gender: All

Summary

The primary aim of the study is to describe the effect of single dose of 10 micrograms (μg) exenatide given subcutaneously (s/c) on cortisol secretion. Secondary outcomes involve ACTH and glucose levels.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Tartu
• Treatments: Exenatide; Hydrocortisone

Criteria

Inclusion Criteria:

• Age 18-50 years

• Body weight >65 kg

Exclusion Criteria:

• Presence of chronic illness

• daily use of any medicines

• pregnancy, lactation

• use of oral contraceptives during previous 2 months